IS
IS · IS · IS-EU/1/25/1941/001
Tepezza
ATC L04AG13
Last synced from Icelandic Medicines Agency (Iceland) on
Identification
ManufacturerAmgen Europe B.V.*
CountryIS (IS)
ATC codeL04AG13
Dispensing—
ReimbursedNo
SourceIcelandic Medicines Agency (Iceland)
Last synced6/9/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Stofn fyrir innrennslisþykkni, lausn",
"source": "lyfjastofnun",
"atc_raw": "L04AG13",
"marketed": false,
"strength": "500 mg",
"ma_number": "EU/1/25/1941/001",
"substance": "Teprotumumab",
"other_info": "Markaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "45827"
}Related drugs
Other records sharing ATC code L04AG13.
- PLTepezzaAmgen Europe B.V.
- 🇺🇸TEPEZZAHorizon Therapeutics USA, Inc.
- DKTEPEZZAAmgen Europe BV
- FITEPEZZAAmgen Europe B.V.
- CZTEPEZZAAmgen Europe B.V., Breda
- BETepezza 500 mgAmgen Europe
- NLTEPEZZA 500 mg poeder voor concentraat voor oplossing voor infusieAmgen Europe B.V.
- 🇪🇸TEPEZZA 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONAmgen Europe B.V.
Access this data programmatically
Query Tepezza and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.